AJOVista LLC Takes $102,000 Position in Lam Research Co. (NASDAQ:LRCX)

AJOVista LLC bought a new position in Lam Research Co. (NASDAQ:LRCX) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 130 shares of the semiconductor company’s stock, valued at approximately $102,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Orion Capital Management LLC purchased a new position in shares of Lam Research in the third quarter valued at about $25,000. BluePath Capital Management LLC purchased a new position in Lam Research during the 3rd quarter valued at about $28,000. OFI Invest Asset Management bought a new position in Lam Research during the 3rd quarter valued at approximately $30,000. Asset Dedication LLC lifted its holdings in Lam Research by 56.7% in the 3rd quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock worth $30,000 after buying an additional 17 shares during the period. Finally, Valued Wealth Advisors LLC bought a new stake in shares of Lam Research in the 4th quarter worth approximately $30,000. 84.61% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have issued reports on LRCX. Evercore ISI started coverage on shares of Lam Research in a research report on Tuesday, April 16th. They set an “outperform” rating and a $1,200.00 price objective on the stock. UBS Group increased their price target on shares of Lam Research from $1,130.00 to $1,150.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. TD Cowen lifted their price objective on Lam Research from $975.00 to $1,000.00 and gave the company a “buy” rating in a research report on Thursday, April 25th. Deutsche Bank Aktiengesellschaft assumed coverage on Lam Research in a research report on Thursday, April 11th. They issued a “hold” rating and a $1,000.00 target price for the company. Finally, Barclays lifted their price target on Lam Research from $825.00 to $865.00 and gave the company an “equal weight” rating in a research report on Thursday, April 25th. Seven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $950.85.

Lam Research Stock Performance

Shares of NASDAQ:LRCX traded up $24.85 during midday trading on Friday, hitting $908.53. The company had a trading volume of 875,385 shares, compared to its average volume of 1,105,338. The company has a market cap of $119.11 billion, a price-to-earnings ratio of 33.41, a PEG ratio of 2.82 and a beta of 1.51. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.82 and a quick ratio of 1.84. The company has a fifty day moving average of $941.31 and a two-hundred day moving average of $817.83. Lam Research Co. has a 12-month low of $507.19 and a 12-month high of $1,007.39.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, April 24th. The semiconductor company reported $7.79 EPS for the quarter, topping the consensus estimate of $7.26 by $0.53. The firm had revenue of $3.79 billion for the quarter, compared to the consensus estimate of $3.72 billion. Lam Research had a return on equity of 45.96% and a net margin of 25.35%. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same quarter last year, the company earned $6.99 earnings per share. On average, equities research analysts expect that Lam Research Co. will post 29.62 EPS for the current fiscal year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were given a dividend of $2.00 per share. The ex-dividend date was Tuesday, March 12th. This represents a $8.00 annualized dividend and a dividend yield of 0.88%. Lam Research’s payout ratio is 29.42%.

Insider Activity at Lam Research

In related news, Director Abhijit Y. Talwalkar sold 882 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $972.03, for a total transaction of $857,330.46. Following the completion of the sale, the director now owns 10,541 shares in the company, valued at $10,246,168.23. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Lam Research news, SVP Seshasayee Varadarajan sold 5,500 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the completion of the transaction, the senior vice president now owns 22,095 shares of the company’s stock, valued at approximately $20,380,648.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Abhijit Y. Talwalkar sold 882 shares of Lam Research stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $972.03, for a total value of $857,330.46. Following the completion of the sale, the director now directly owns 10,541 shares in the company, valued at $10,246,168.23. The disclosure for this sale can be found here. In the last quarter, insiders have sold 7,089 shares of company stock worth $6,614,781. 0.32% of the stock is owned by corporate insiders.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.